Fatty Acid Metabolism in Aggressive B Cell Lymphoma Is Inhibited by Tetraspanin CD37

Scientists identified tetraspanin CD37, a prognostic marker for aggressive B cell lymphoma, as essential membrane-localized inhibitor of fatty acid metabolism.